Rodrigo Martino

18.9k total citations
313 papers, 10.4k citations indexed

About

Rodrigo Martino is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Rodrigo Martino has authored 313 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 100 papers in Oncology and 80 papers in Epidemiology. Recurrent topics in Rodrigo Martino's work include Hematopoietic Stem Cell Transplantation (138 papers), Acute Myeloid Leukemia Research (57 papers) and Acute Lymphoblastic Leukemia research (39 papers). Rodrigo Martino is often cited by papers focused on Hematopoietic Stem Cell Transplantation (138 papers), Acute Myeloid Leukemia Research (57 papers) and Acute Lymphoblastic Leukemia research (39 papers). Rodrigo Martino collaborates with scholars based in Spain, Germany and United States. Rodrigo Martino's co-authors include Jorge Sierra, Salut Brunet, Anna Sureda, David Valcárcel, Javier Briones, Rafael de la Cámara, Josè Antonio Pérez-Simón, Albert Altés, Jesús F. San Miguel and Catherine Cordonnier and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rodrigo Martino

307 papers receiving 10.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rodrigo Martino Spain 56 5.1k 3.4k 2.8k 2.0k 1.9k 313 10.4k
Jan J. Cornelissen Netherlands 58 7.1k 1.4× 2.6k 0.8× 3.4k 1.2× 1.5k 0.8× 2.9k 1.6× 319 13.0k
Nöel Milpied France 65 6.1k 1.2× 2.2k 0.6× 5.3k 1.9× 1.5k 0.8× 2.7k 1.5× 423 13.9k
Simone Cesaro Italy 47 2.9k 0.6× 2.9k 0.8× 2.6k 0.9× 2.4k 1.2× 1.3k 0.7× 289 8.3k
Amelia Langston United States 41 2.3k 0.5× 2.7k 0.8× 2.1k 0.8× 2.4k 1.2× 884 0.5× 177 7.5k
Catherine Cordonnier France 65 3.2k 0.6× 7.5k 2.2× 3.9k 1.4× 4.8k 2.4× 1.5k 0.8× 246 13.1k
Tapani Ruutu Finland 51 6.8k 1.3× 1.3k 0.4× 2.1k 0.8× 845 0.4× 1.5k 0.8× 221 10.2k
Georg Maschmeyer Germany 47 1.9k 0.4× 3.0k 0.9× 3.3k 1.2× 2.6k 1.3× 524 0.3× 194 8.3k
Jan Storek Canada 45 4.1k 0.8× 2.4k 0.7× 2.0k 0.7× 875 0.4× 3.0k 1.6× 187 7.6k
Miguel‐Angel Perales United States 52 3.0k 0.6× 1.4k 0.4× 4.7k 1.7× 1.5k 0.8× 3.0k 1.6× 450 10.1k
Rein Saral United States 55 4.1k 0.8× 4.0k 1.2× 3.4k 1.2× 2.7k 1.3× 1.4k 0.8× 134 11.3k

Countries citing papers authored by Rodrigo Martino

Since Specialization
Citations

This map shows the geographic impact of Rodrigo Martino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Martino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Martino more than expected).

Fields of papers citing papers by Rodrigo Martino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodrigo Martino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Martino. The network helps show where Rodrigo Martino may publish in the future.

Co-authorship network of co-authors of Rodrigo Martino

This figure shows the co-authorship network connecting the top 25 collaborators of Rodrigo Martino. A scholar is included among the top collaborators of Rodrigo Martino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodrigo Martino. Rodrigo Martino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caballero, A, Irene García‐Cadenas, Albert Esquirol, et al.. (2025). HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma. Blood. 145(16). 1788–1801.
2.
3.
León, Andrés Gómez‐De, Irene García‐Cadenas, Perla R. Colunga‐Pedraza, et al.. (2024). Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study. Blood. 144(Supplement 1). 4898–4898.
4.
Piñana, José Luís, Estela Giménez, Lourdes Vázquez, et al.. (2024). UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024065–e2024065. 1 indexed citations
5.
Moga, Esther, Sílvia Vidal, Iria González, et al.. (2023). mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. Leukemia Research. 132. 107347–107347. 2 indexed citations
6.
Morgades, Mireia, Carlos Pinho Vaz, Rebeca Bailén, et al.. (2023). Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation. European Journal Of Haematology. 110(6). 659–668. 4 indexed citations
7.
Piñana, José Luís, Ariadna Pérez, Manuel Guerreiro, et al.. (2023). Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Transplant Infectious Disease. 25(S1). e14117–e14117. 9 indexed citations
8.
Moreno, E., et al.. (2023). Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study. Transplantation and Cellular Therapy. 29(6). 385.e1–385.e8. 5 indexed citations
9.
Piñana, José Luís, Ramón García‐Sánz, Rodrigo Martino, et al.. (2021). Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19. Blood Advances. 6(3). 848–853. 2 indexed citations
10.
Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations
11.
Cuéllar‐García, Carolina, Salut Brunet, Javier Briones, et al.. (2018). Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy. Clinical Lymphoma Myeloma & Leukemia. 18(11). 737–742. 2 indexed citations
12.
Aguilar‐Guisado, Manuela, Ildefonso Espigado, Montserrat Rovira, et al.. (2011). Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study. Clinical Transplantation. 25(6). E629–E638. 52 indexed citations
13.
Cámara, Rafael de la, Manuel Abecasis, Catherine Cordonnier, et al.. (2011). Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 96(8). 1231–1235. 83 indexed citations
14.
Barkholt, Lisbeth, Marco Bregni, Mats Remberger, et al.. (2006). Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Annals of Oncology. 17(7). 1134–1140. 58 indexed citations
15.
Subirá, Maricel, Anna Sureda, Rodrigo Martino, et al.. (2003). Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure. Bone Marrow Transplantation. 32(9). 869–872. 17 indexed citations
16.
Ljungman, Per, Bruce Crooks, Anne Parker, et al.. (2001). Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 28(5). 479–484. 226 indexed citations
17.
18.
Barrett, A. John, Olle Ringdén, Mei‐Jie Zhang, et al.. (2000). Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.. Blood. 95(11). 3323–3327. 66 indexed citations
19.
Mateo, José, et al.. (1993). Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia. Annals of Hematology. 67(6). 309–311. 16 indexed citations
20.
Martino, Rodrigo, et al.. (1993). Treatment of Refractory and Relapsed Adult Acute Leukemia Using a Uniform Chemotherapy Protocol. Leukemia & lymphoma. 11(5-6). 393–398. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan J. Cornelissen Breakdown of academic impact, for papers by Nöel Milpied Breakdown of academic impact, for papers by Simone Cesaro Breakdown of academic impact, for papers by Amelia Langston Breakdown of academic impact, for papers by Catherine Cordonnier Breakdown of academic impact, for papers by Tapani Ruutu Breakdown of academic impact, for papers by Georg Maschmeyer Breakdown of academic impact, for papers by Jan Storek Breakdown of academic impact, for papers by Miguel‐Angel Perales Breakdown of academic impact, for papers by Rein Saral
Rankless by CCL
2026